Anebulo Pharmaceuticals
phase proof of concept clinical trial | Anebulo Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
22 of 53
Related slides by other companies
NeuroSense Therapeutics
Investor Presentation
June 2023
milestones achieved upcoming potential catalysts | NeuroSense Therapeutics
Mink Therapeutics
IPO
October 2021
phase clinical trial focused in acute | Mink Therapeutics
Mink Therapeutics
IPO
October 2021
phase clinical trial focused in induced | Mink Therapeutics
BioNTech
Results
May 2020
global clinical development program ongoing prime boost vaccine prime only vaccine | BioNTech
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights